Researchers find narcolepsy symptoms the most severe in patients taking dopamine agonists, so clinicians should be cautious in using them.
Sodium oxybate, alone or in combination with modafinil, improved excessive sleepiness in patients with narcolepsy both with and without cataplexy.
Post-hoc analysis of Phase IIb trial finds both clinician and patient-reported improvements in disease status with JZP-110.
The first trial to evaluate sodium oxybate for the treatment of children and adolescents with narcolepsy and cataplexy has started patient enrollment.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Distinct Characteristics in Children at Risk for Schizophrenia vs Bipolar Disorder
- Nonstimulants May Be an Appropriate Alternative to Stimulants for Treating ADHD
- Psychotic Experiences Associated With Increased Risk for Eating Disorders in Adolescents
- Novel Parent-Child Interaction Therapy Targets Preschool-Aged Depression
- Remission of Treatment-Resistant Depression in Veterans Depends on Close Clinical Observation
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations
- From Abused Child to Serial Killer: Investigating Nature vs Nurture in Methods of Murder
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Should Physicians Treat Family and Friends? Three Experts Weigh In
- When Physicians Become Patients: Challenges in Seeking Health Care
- Long-Acting Injectables Effective in Patients With Comorbid Psychosis, Substance Use Disorder
- Strong Social Networks May Mitigate the Effects of Childhood Adversity
- Electroconvulsive Therapy Improves Global Cognition in Bipolar Disorder
- FOSTA-SESTA Threatens Sex Worker Livelihoods: What Mental Health Providers Should Know